Cytomegalovirus cultured from different major leukocyte subpopulations: Association with clinical features in CMV immunoglobulin G-positive renal allograft recipients

• Published in: Journal of medical virology 2000-08, Vol.61 (4), p.488-496
• Main Authors: Schäfer, Peter, Tenschert, Werner, Cremaschi, Liana, Schröter, Matthias, Gutensohn, Kai, Laufs, Rainer
• Format: Article
• Language: English
• Subjects: antigenemia; Biological and medical sciences; Cells, Cultured; CMV disease; Cytomegalovirus; Cytomegalovirus - genetics; Cytomegalovirus - isolation & purification; Cytomegalovirus Infections - immunology; Cytomegalovirus Infections - virology; DNA, Viral - blood; DNA-emia; endothelial cells; Endothelium, Vascular - cytology; Human viral diseases; Humans; Immunoglobulin G - blood; Infectious diseases; Kidney Transplantation - immunology; Leukocytes, Mononuclear - virology; Medical sciences; Neutrophils - virology; Phosphoproteins - blood; Polymerase Chain Reaction; quantitative PCR; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; Viral Matrix Proteins - blood; Viremia
• ISSN: 0146-6615; 1096-9071
• DOI: 10.1002/1096-9071(200008)61:4<488::AID-JMV12>3.0.CO;2-7

Cytomegalovirus (CMV) cultured from peripheral blood mononuclear cells (PBMCs) was shown to be associated more closely with clinical manifestations than infectious CMV in polymorphonuclear leukocytes (PMNLs) of renal allograft recipients with secondary CMV infection. Shell vial culture was carried out with ficoll‐purified PBMCs and PMNLs of 71 CMV IgG‐positive patients after kidney transplantation. Thirty‐six patients experienced active CMV infections. Of these, 17 developed clinical symptoms. The diagnostic value of PMNLs and PBMCs viremia was determined in comparison to pp65 antigenemia, leukoDNAemia, plasma DNAemia, and detection of cytomegalic endothelial cells. In both PMNLs and PBMCs (with or without detectable endothelial cells), frequencies and levels of viremia were significantly higher among symptomatic patients. Regarding the occurrence of clinical CMV manifestations, the sensitivity of culture from PMNLs and from PBMCs fractions was 100%. Viremia in PBMCs, however, was far more specific (94%) than in PMNLs (74%). Cutoff values established previously for pp65 antigenemia and leukoDNAemia, standard markers in the laboratory, had similar specificity (96% each) to PBMCs viremia, but were less sensitive (88% each). Plasma DNA‐emia was both less sensitive (82%) and less specific (69%) than PBMCs viremia. Detection of endothelemia showed maximal specificity (100%), but inferior sensitivity (47%). All patients had PBMCs viremia before the onset of symptoms. In conclusion, infectious CMV present in PBMCs may prove to be a determinant of clinical CMV manifestations in seropositive immunocompromised individuals. Factors involved in PBMCs tropism may help to understand the pathogenetic mechanisms of CMV dissemination in this group of patients. J. Med. Virol. 61:488–496, 2000. © 2000 Wiley‐Liss, Inc.